Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: puborectalis who wrote (643)	2/15/1999 11:17:00 AM
From: Biomaven	Respond to of 2001

Stephen, That's an interesting collection of losers you cite. Take a look at one of Rick's very early warning posts on Viragen: Message 401182 That's when the stock was around 9. Similarly, you'll find a post by me on the VDXX thread suggesting HMSC as a short when the stock was in the teens and going gangbusters: Message 3584284 (with my rationale a few posts further along). I happen to know that Rick was about to buy CLPA puts when it crashed. Yes, individual small biotechs are very risky, even the better ones like NRGN. However a combination of avoiding the obvious dogs and buying a diversified basket of good ones can be very rewarding. GLIA is becoming one of the select few biotechs that are profitable and have a reasonable pipeline - maybe just what someone like J&J might want to fatten their own thin pipeline (see the munch-a-biotech thread for more on this discussion). Peter